Inventor · disambiguated record
Kimberly O. Cameron
Also filed as: CAMERON KIMBERLY · CAMERON KIMBERLY O · CAMERON KIMBERLY O'KEEFE
34 granted patents·12 pending applications·725 citations·filing 1994–2024
98Inventor score
Top patents by PatentIndex Score
46 records- 0197US5552412A5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosisPFIZER·Filed 1995·Granted Sep 3, 1996·194 cites·11 claims
- 0295US6552067B2EP4 receptor selective agonists in the treatment of osteoporosisPFIZER·Filed 2001·Granted Apr 22, 2003·57 cites·11 claims
- 0390US6204286B1Estrogen agonists/antagonistsPFIZER·Filed 1995·Granted Mar 20, 2001·62 cites·20 claims
- 0490US6153622AEstrogen agonists/antagonistsPFIZER·Filed 1998·Granted Nov 28, 2000·59 cites·25 claims
- 0589US7265104B2Tetraazabenzo[e]azulene derivatives and analogs thereofPFIZER·Filed 2005·Granted Sep 4, 2007·13 cites·37 claims
- 0688US6747054B2EP4 receptor selective agonists in the treatment of osteoporosisPFIZER·Filed 2002·Granted Jun 8, 2004·24 cites·24 claims
- 0785US6649657B2Prevention of loss and restoration of bone mass by certain prostaglandin agonistsPFIZER·Filed 2002·Granted Nov 18, 2003·16 cites·49 claims
- 0883USRE39558E5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosisPFIZER·Filed 2004·Granted Apr 10, 2007·10 cites·16 claims
- 0982US6441193B1Estrogen agonists/antagonistsPFIZER·Filed 1999·Granted Aug 27, 2002·28 cites·3 claims
- 1082US6124314AOsteoporosis compoundsPFIZER·Filed 1998·Granted Sep 26, 2000·42 cites·17 claims
- 1181US6608203B2Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsPFIZER·Filed 2000·Granted Aug 19, 2003·13 cites·57 claims
- 1280US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 1379US6492412B2Prevention of loss and restoration of bone mass by certain prostaglandin agonistsPFIZER·Filed 2001·Granted Dec 10, 2002·9 cites·104 claims
- 1476US7192979B2EP4 receptor selective agonist in the treatment of osteoporosisPFIZER·Filed 2003·Granted Mar 20, 2007·7 cites·21 claims
- 1576US6642266B2EP4 receptor selective agonists in the treatment of osteoporosisPFIZER·Filed 2001·Granted Nov 4, 2003·7 cites·15 claims
- 1676US6288120B1Prevention of loss and restoration of bone mass by certain prostaglandin agonistsPFIZER·Filed 1997·Granted Sep 11, 2001·30 cites·124 claims
- 1775US6376502B1Osteoporosis compoundsPFIZER·Filed 2000·Granted Apr 23, 2002·6 cites·36 claims
- 1873US7358242B2Tetraazabenzo[e]azulene derivatives and analogs thereofPFIZER·Filed 2007·Granted Apr 15, 2008·1 cites·12 claims
- 1973US6852863B2Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acidPFIZER·Filed 2003·Granted Feb 8, 2005·7 cites·8 claims
- 2073US6531485B2Prostaglandin agonistsPFIZER·Filed 1998·Granted Mar 11, 2003·18 cites·7 claims
- 2173US6498172B1Prostaglandin agonists and their use to treat bone disordersPFIZER·Filed 1998·Granted Dec 24, 2002·25 cites·12 claims
- 2271US6737437B2EP4 receptor selective agonists in the treatment of osteoporosisPFIZER·Filed 2000·Granted May 18, 2004·4 cites·13 claims
- 2371US5703108ABone deposition by certain prostaglandin agonistsPFIZER·Filed 1997·Granted Dec 30, 1997·35 cites·16 claims
- 2470US7414071B2Methods of treatment with selective EP4 receptor agonistsPFIZER·Filed 2003·Granted Aug 19, 2008·6 cites·9 claims
- 2570US7053212B2Acyclic amide and sulfonamide ligands for the estrogen receptorPFIZER·Filed 2003·Granted May 30, 2006·4 cites·7 claims
- 2669US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 2768US6998423B2Prevention of loss and restoration of bone mass by certain prostaglandin agonistsPFIZER·Filed 2003·Granted Feb 14, 2006·2 cites·36 claims
- 2866US7442702B2Prostaglandin agonistsPFIZER·Filed 2002·Granted Oct 28, 2008·2 cites·35 claims
- 2965US2024336572A1Substituted indazole propionic acid derivative compounds and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 3062US8609680B22,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivativesBHATTACHARYA SAMIT K·Filed 2011·Granted Dec 17, 2013·1 cites·13 claims
- 3162US2024182468A1Compounds for the activation of ampkPFIZER·Filed 2023·Application pending·0 cites
- 3257US6426359B1Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonistsPFIZER·Filed 1997·Granted Jul 30, 2002·12 cites·19 claims
- 3357US2010317712A1Estrogen Agonists/Antagonists For Preventing Breast CancerCAMERON KIMBERLY O·Filed 2010·Application pending·0 cites
- 3455US6756388B1Benzothiophenes and related compounds as estrogen agonistsPFIZER·Filed 1994·Granted Jun 29, 2004·11 cites·3 claims
- 3554US2004192685A1Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsFiled 2004·Application pending·0 cites
- 3654US2002132816A1Estrogen agonists/antagonists for preventing breast cancerFiled 2002·Application pending·0 cites
- 3753US6344485B1Method for treating glaucomaPFIZER·Filed 1999·Granted Feb 5, 2002·14 cites·24 claims
- 3852US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 3952US2003220494A1Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsFiled 2003·Application pending·0 cites
- 4052US2001025051A1Estrogen agonists/antagonists for preventing breast cancerFiled 2001·Application pending·0 cites
- 4151US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 4250US12466803B2BCKDK inhibitors and/or degradersPFIZER·Filed 2022·Granted Nov 11, 2025·0 cites·16 claims
- 4350US2002165255A1Osteoporosis compoundsFiled 2001·Application pending·0 cites
- 4450US2014080756A12,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivativesPFIZER·Filed 2013·Application pending·0 cites
- 4544US2003176479A1Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertensionFiled 2003·Application pending·0 cites
- 4639US2001056060A1Treatment of osteoporsis with EP2/EP4 receptor selective agonistsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kimberly O. Cameron files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →